Kestra Medical (KMTS) CFO receives 25,227 RSUs vesting over three years

Rhea-AI Filing Summary

Mahboob Vaseem reported acquisition or exercise transactions in this Form 4 filing.

Kestra Medical Technologies Chief Financial Officer Mahboob Vaseem reported an equity compensation grant in the form of restricted stock units. He was awarded 25,227 RSUs that each entitle him to receive one common share at settlement. Subject to his continued service, one third of these RSUs will vest on each anniversary of June 3, 2026, over a three-year period. Following this grant, he beneficially owns 67,961 common shares, which include 5,837 common shares received in a prior pro rata distribution from West Affum Holdings, L.P. that was exempt under Rule 16a-9.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mahboob Vaseem

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	25,227	$0.00	--

Holdings After Transaction: Common Shares — 67,961 shares (Direct, null)

Footnotes (1)

1. Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. ("Common Share"). Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026. Includes 5,837 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.

Key Figures

RSU grant size: 25,227 RSUs Vesting schedule: 1/3 per year over 3 years Total beneficial ownership: 67,961 common shares +1 more

4 metrics

RSU grant size 25,227 RSUs Restricted stock units awarded to CFO on June 3, 2026 vesting schedule

Vesting schedule 1/3 per year over 3 years RSUs vest on each anniversary of June 3, 2026, subject to continued service

Total beneficial ownership 67,961 common shares Shares reported as beneficially owned after the RSU grant

Shares from distribution 5,837 common shares Received from West Affum Holdings, L.P. via pro rata distribution under Rule 16a-9

Key Terms

restricted stock units, RSU, pro rata distribution, Rule 16a-9, +1 more

5 terms

restricted stock units financial

"Represents restricted stock units ("RSU") that entitle the Reporting Person to receive"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Represents restricted stock units ("RSU") that entitle the Reporting Person to receive"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

pro rata distribution financial

"Includes 5,837 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution"

A pro rata distribution is when a company or organization shares out money, assets, or benefits evenly among all eligible people based on their size or share. For example, if a company makes a profit and distributes it to shareholders, each person gets a portion proportional to how many shares they own. It ensures everyone gets their fair part based on their ownership or stake.

Rule 16a-9 regulatory

"received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9"

vest over three years financial

"Subject to the Reporting Person's continued service, the RSUs will vest over three years"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mahboob Vaseem

(Last) (First) (Middle)

3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)

KIRKLAND WASHINGTON 98033

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	06/03/2026		A		25,227(1)	A	$0	67,961(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. ("Common Share"). Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.

2. Includes 5,837 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.

	/s/ Traci S. Umberger as attorney-in-fact for Vaseem Mahboob	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Kestra Medical (KMTS) CFO Mahboob Vaseem report?

Mahboob Vaseem reported receiving a grant of 25,227 restricted stock units (RSUs) tied to Kestra Medical common shares. These RSUs are an equity compensation award rather than an open-market purchase or sale, and they vest over time based on continued service.

How many RSUs did the Kestra Medical (KMTS) CFO receive and how do they vest?

The CFO received 25,227 RSUs, each convertible into one Kestra Medical common share at settlement. The RSUs vest over three years, with one third vesting on each anniversary of June 3, 2026, assuming he continues to serve the company.

What is Mahboob Vaseem’s total Kestra Medical (KMTS) share position after this grant?

After the RSU grant, Mahboob Vaseem is reported as beneficially owning 67,961 Kestra Medical common shares. This total includes 5,837 common shares he previously received in a pro rata distribution from West Affum Holdings, L.P., exempt under Rule 16a-9.

What are restricted stock units (RSUs) in the context of Kestra Medical (KMTS)?

In this context, RSUs are awards that entitle the holder to receive one common share at settlement, subject to vesting conditions. For Kestra Medical, the CFO’s 25,227 RSUs vest over three years if he continues serving the company.

What is the significance of the 5,837 Kestra Medical (KMTS) shares from West Affum Holdings, L.P.?

The filing notes that 5,837 common shares were received by the CFO in a pro rata distribution from West Affum Holdings, L.P. This transaction was exempt under SEC Rule 16a-9 and is included in his reported beneficial ownership.